Agenda
The Combination Products Strategic Committee is working diligently on the 2025 program line-up, carefully reviewing feedback from last year and suggestions provided as part of our open survey to the combination products community earlier this year. Their focus is to ensure the highest quality discussions, knowledge exchange, and collaboration opportunities.
Here is just a glimpse of what you can expect in Providence this November!
Program Topics
Global Harmonization in the Diverging Combination Products Space
EDDO Control Strategies
Digital Health – Application of Good Machine Learning Practices
Clinical Investigations for Combined Use Systems (a global view)
Drug-Delivery Device Clinical Bridging: Leverage Platform Approach and Prior Knowledge
Navigating Human Factors for Combination Products (including Generic: URRA, Threshold Analysis and Post Market)
Navigating the Post-Market Landscape of Combination Products: Surveillance Best Practices, Risk Management and Change Management
Challenges of Supplier and Partner Relationships
Clinical Strategies
Lunchtime Table Topics
Hot Topics in Quality
Drug Delivery Systems: Home Use/Self-Administration Labeling Claims
Device-Led Combination Products
Cross-Labeled Products
Submissions
